Royal London Asset Management
ELV icon

Royal London Asset Management’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$93.1M Sell
239,386
-2,715
-1% -$1.06M 0.21% 92
2025
Q1
$105M Buy
242,101
+10,792
+5% +$4.69M 0.25% 79
2024
Q4
$85.3M Buy
231,309
+2,049
+0.9% +$756K 0.21% 86
2024
Q3
$119M Buy
229,260
+5,960
+3% +$3.1M 0.29% 67
2024
Q2
$121M Sell
223,300
-23,601
-10% -$12.8M 0.31% 63
2024
Q1
$128M Buy
246,901
+14,381
+6% +$7.46M 0.32% 64
2023
Q4
$110M Buy
232,520
+1,962
+0.9% +$925K 0.31% 64
2023
Q3
$100M Buy
230,558
+9,750
+4% +$4.25M 0.33% 60
2023
Q2
$98.1M Buy
220,808
+50,402
+30% +$22.4M 0.32% 59
2023
Q1
$78.3M Buy
170,406
+6,007
+4% +$2.76M 0.31% 63
2022
Q4
$84.4M Buy
164,399
+1,400
+0.9% +$719K 0.38% 54
2022
Q3
$74.2M Sell
162,999
-8,576
-5% -$3.9M 0.38% 53
2022
Q2
$82.8M Sell
171,575
-3,130
-2% -$1.51M 0.38% 56
2022
Q1
$85.8M Buy
174,705
+17,806
+11% +$8.75M 0.34% 58
2021
Q4
$72.7M Sell
156,899
-10,901
-6% -$5.05M 0.27% 71
2021
Q3
$62.5M Buy
167,800
+582
+0.3% +$217K 0.25% 80
2021
Q2
$63.8M Sell
167,218
-8,895
-5% -$3.4M 0.26% 80
2021
Q1
$63.2M Buy
176,113
+6,453
+4% +$2.32M 0.29% 74
2020
Q4
$54.5M Buy
169,660
+2,870
+2% +$922K 0.29% 77
2020
Q3
$43.3M Sell
166,790
-67,655
-29% -$17.6M 0.26% 82
2020
Q2
$54.4M Buy
234,445
+85,826
+58% +$19.9M 0.38% 60
2020
Q1
$34.3M Buy
+148,619
New +$34.3M 0.28% 83
2019
Q4
Sell
-147,436
Closed -$35.4M 646
2019
Q3
$35.4M Buy
+147,436
New +$35.4M 0.27% 89
2019
Q2
Sell
-146,713
Closed -$42.1M 602
2019
Q1
$42.1M Buy
146,713
+7,266
+5% +$2.09M 0.33% 73
2018
Q4
$36.1M Buy
+139,447
New +$36.1M 0.32% 75
2014
Q4
Sell
-66,169
Closed -$8.02M 522
2014
Q3
$8.02M Buy
66,169
+642
+1% +$77.8K 0.2% 117
2014
Q2
$7.3M Sell
65,527
-244
-0.4% -$27.2K 0.17% 142
2014
Q1
$7.04M Sell
65,771
-5,242
-7% -$561K 0.16% 146
2013
Q4
$6.53M Sell
71,013
-2,856
-4% -$263K 0.17% 142
2013
Q3
$6.18M Buy
73,869
+567
+0.8% +$47.4K 0.17% 138
2013
Q2
$5.99M Buy
+73,302
New +$5.99M 0.17% 130